7. A phlebotomist is preparing to draw blood from a patient for therapeutic drug monitoring. Which of the following questions should the phlebotomist ask?

Answer: A

Explanation:

When was your last dose of lithium?

Asking the patient when their last dose of lithium was taken is essential for therapeutic drug monitoring, as it helps the phlebotomist determine the optimal timing for blood collection to assess the drug's levels accurately.

A) When was your last dose of lithium?

This option is correct because it directly relates to the purpose of therapeutic drug monitoring. Knowing the timing of the last dose allows for accurate interpretation of the blood test results and ensures that the drug levels are measured at the appropriate time, reflecting the patient's therapeutic range.

B) For how long have you been fasting?

While fasting can be important for certain tests, it is not specifically relevant to therapeutic drug monitoring for lithium. This question does not provide necessary information for understanding the drug levels in the patient's system.

C) When did you have your last alcoholic beverage?

Although alcohol consumption can affect various health aspects, this question is not directly pertinent to monitoring lithium levels. It does not provide crucial information necessary for assessing the therapeutic levels of the drug and could distract from the primary purpose of the blood draw.

D) Have you finished drinking the glucose solution?

This option is unrelated to lithium monitoring. The glucose solution is typically associated with glucose tolerance tests rather than therapeutic drug monitoring, making this question irrelevant in the context of assessing lithium levels.

Conclusion

The question regarding the last dose of lithium is critical for effective therapeutic drug monitoring, ensuring that the phlebotomist obtains accurate and meaningful test results. The other options fail to address the specific requirements for monitoring lithium therapy, as they pertain to different tests or factors that do not directly influence drug level assessments.